Results 191 to 200 of about 756,852 (217)

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis

Expert Opinion on Investigational Drugs, 2021
John Vissing, Kimiaki Utsugisawa, M Isabel Leite   +2 more
exaly  

Myasthenia gravis: general features

2021
openaire   +1 more source

Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United States

Journal of the Neurological Sciences, 2022
Yuebing Li, Glenn Phillips, Tom Hughes
exaly  

Thymectomy in thymomatous generalized myasthenia gravis: An analysis of the prognosis and risk factors

European Journal of Neurology, 2023
Jinwei Zhang, Peng Zhang, Peng Zhang
exaly  

Development of Generalized Disease at 2 Years in Patients With Ocular Myasthenia Gravis

Archives of Neurology, 2003
Mark J Kupersmith
exaly  

Risk of Ocular Myasthenia Gravis Transitioning to Generalized Myasthenia Gravis

Qing Zhou, Jian Chen
openaire   +1 more source

Generalized trichoepitheliomas with alopecia and myasthenia gravis

Journal of the American Academy of Dermatology, 1988
S. Miyakawa, Y. Araki, M. Sugawara
openaire   +1 more source

Seronegative autoimmune generalized Myasthenia Gravis

Journal of Autoimmunity, 1989
C. Casali, S. D'Agostini, I. La Cesa, A. Peppe, C. Scoppetta   +4 more
openaire   +1 more source

The effect of prednisone on the progression from ocular to generalized myasthenia gravis

Journal of the Neurological Sciences, 2004
Jonathan M Goldstein
exaly  

Low conversion rate of ocular to generalized myasthenia gravis in Singapore

Muscle and Nerve, 2018
Benjamin Haaland, Dan Milea
exaly